Active ingredientPiretanideCat. No. P-P133-001CAS 55837-27-9Family · Pharmaceutical analytical standards
Piretanide
A loop diuretic synthesised in 1973 and approved for medical use in 1981, used as a saluretic, that is to increase the excretion of salt in the urine, and as an antihypertensive. This family brings together the active ingredient and pharmacopoeial impurities.
Did you know?To build its molecule, chemists used a then-new method for attaching a cyclic amine ring, pyrrolidine, to an aromatic ring.
Go to the active ingredient →Active ingredientPiretanideCat. No. P-P133-001CAS 55837-27-9
Pharmacopoeial impurityPiretanide EP Impurity ACat. No. P-P133-002CAS 67641-46-7
Pharmacopoeial impurityPiretanide EP Impurity BCat. No. P-P133-003CAS 60376-76-3
Pharmacopoeial impurityPiretanide EP Impurity CCat. No. P-P133-004No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substancePiretanide CRSEDQM code P2120000Family PiretanideNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.